Peer Reviewed
This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
Tiffany Tam, PharmD, BCOP
Advertisement
Articles by Tiffany Tam, PharmD, BCOP
Advertisement
Latest Updated Articles
A Review of Anti-HER2 Targeted Agents in Non-Breast Solid TumorsFebruary 14th 2024
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Key Pharmacotherapy Advances in Type 1 and Type 2 Diabetes
2
McKesson ideaShare 2026: Health Mart and Health Mart Atlas’ Role in Supporting Independent Pharmacies in 2026
3
World Psychedelics Day: Why Pharmacy Can't Sit This One Out
4
McKesson ideaShare 2026: Why Automation and AI Are Reshaping the Dispensing Experience
5